Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX)

CUSIP: 03168L105

Q2 2026 13F Holders as of 30 Jun 2026

Holder snapshot 6 signals
Share change
+91,627
SEC-reported price per share
$17.31
Number of holders
11
Value change
+$1,586,049
Number of buys
6
Number of sells
2
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
313,041,907

Security key

03168L105

Report period

Q2 2026

Institutions

11

Top holders

10

Ownership snapshot

Top reported holders of AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Tushar Bhikhubhai Patel
Disclosed value leader
Tushar Bhikhubhai Patel
Comparable rows
15/15
Latest evidence
31 Mar 2026
3/4/5 13D/G 13F Lead comparable stake: 16% 13D/G row: Tushar Bhikhubhai Patel Showing 1-6 of 15 holder rows.

Quick read

Tushar Bhikhubhai Patel leads the comparable SEC ownership view at 16%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Tushar Bhikhubhai Patel's linked filing trail.
Comparable ownership Top 5
Tushar Bhikhubhai Patel 16%
Patel Chintu 8.2%
Patel Chirag K. 7.1%
Akram Mahesh 6.6%
Dipan Patel 5.4%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Tushar Bhikhubhai Patel
3/4/5 13D/G
10%+ Owner · Patel Tushar Bhikhubhai
16%
from 13D/G
$405,628,045
48,578,209 shares
14 Mar 2025
Patel Chintu
3/4/5 13D/G
Co-CEO, Director
8.2%
from 13D/G
$387,552,566
26,326,958 shares
mixed-class rows
03 Mar 2026
Patel Chirag K.
3/4/5 13D/G
President & Co-CEO, Director
7.1%
from 13D/G
$337,352,284
22,848,075 shares
mixed-class rows
03 Mar 2026
Akram Mahesh
13D/G
6.6%
$153,779,517
20,558,759 shares
$0 31 Mar 2025
Dipan Patel
13D/G 3/4/5
Patel Dipan · Member of 13D Group
5.4%
$244,942,771
16,904,263 shares
-$100,339,323 31 Dec 2025
VANGUARD GROUP INC
13D/G
The Vanguard Group
5%
$117,905,198
15,762,727 shares
$0 31 Mar 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
11
Shares
3,431,416
Rows available
11
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2026 vs Q1 2026 Across Filers

Q1 2026 holders
314
Q2 2026 holders
11
Holder diff
-303
Investor Q1 2026 Shares Q2 2026 Shares Share Diff Share Chg % Q1 2026 value Q2 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .